Volume 19, Number 11—November 2013
Dispatch
Severe Plasmodium vivax Malaria in Pakistan
Table 1
Demographic profile of study participants with Plasmodium vivax and P. falciparum malaria, Karachi, Pakistan, 2009–2011*
Characteristic |
Frequency (%) |
||
---|---|---|---|
P. vivax |
P. falciparum |
Mixed |
|
Sex | |||
F | 98 (33) | 12 (25) | 6 (46) |
M | 198 (67) | 35 (75) | 7 (54) |
Previously healthy adults | 189 (64) | 30 (64) | 10 (77) |
Concurrent illness | |||
Diabetes | 49 (17) | 4 (9) | 0 |
Ischemic heart disease | 37 (12) | 2 (4) | 3 (23) |
Chronic kidney disease | 10 (3) | 3 (6) | 0 |
Co-existing infection† | 34 (12) | 5 (11) | 0 |
Others‡ | 10 (3) | 5 (11) | 0 |
Total§ | 107 (36) | 17 (36) | 3 (23) |
*n = 356.
†Co-existing infections included dengue fever, urinary tract infection, enteric fever, and hepatitis C, diagnosed by appropriate serologic testing/culture.
‡Other conditions included chronic obstructive pulmonary disease, chronic liver disease, malignancy, and other conditions from the Charlson Comorbidity Index (5).
§Many patients had multiple comorbidities; therefore, the total does not sum the above.
References
- World Health Organization. World malaria report: 2011. Geneva: The Organization; 2011.
- World Health Organization. Guidelines for the treatment of malaria, 2nd ed. Geneva: The Organization; 2010.
- Sharma A, Khanduri U. How benign is benign tertian malaria? J Vector Borne Dis. 2009;46:141–4 .PubMed
- Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80:194–8 .PubMed
Page created: October 31, 2013
Page updated: October 31, 2013
Page reviewed: October 31, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.